In addition, TGF-β reduces the cytotoxicity of CD8+ T cells by impairing their secretion of perforin, granzyme, and IFNγ (129), which are imperative for CTL-mediated tumor killing (130). The gene discussed is CD8A; the disease is neoplasm.